Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark : a nationwide Study. / Sloth Mathiesen, Jes; Kroustrup, Jens Peter; Vestergaard, Peter; Krag, Kirstine Stochholm; Poulsen, Per Løgstrup; Rasmussen, Åse Krogh; Feldt-Rasmussen, Ulla; Gaustadnes, Mette; Ørntoft, Torben Falck; Rossing, Maria; Nielsen, Finn Cilius; Albrechtsen, Anders; Brixen, Kim; Godballe, Christian; Frederiksen, Anja Lisbeth.

In: Thyroid, Vol. 27, No. 12, 12.2017, p. 1505-1510.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sloth Mathiesen, J, Kroustrup, JP, Vestergaard, P, Krag, KS, Poulsen, PL, Rasmussen, ÅK, Feldt-Rasmussen, U, Gaustadnes, M, Ørntoft, TF, Rossing, M, Nielsen, FC, Albrechtsen, A, Brixen, K, Godballe, C & Frederiksen, AL 2017, 'Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide Study', Thyroid, vol. 27, no. 12, pp. 1505-1510. https://doi.org/10.1089/thy.2017.0404

APA

Sloth Mathiesen, J., Kroustrup, J. P., Vestergaard, P., Krag, K. S., Poulsen, P. L., Rasmussen, Å. K., Feldt-Rasmussen, U., Gaustadnes, M., Ørntoft, T. F., Rossing, M., Nielsen, F. C., Albrechtsen, A., Brixen, K., Godballe, C., & Frederiksen, A. L. (2017). Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide Study. Thyroid, 27(12), 1505-1510. https://doi.org/10.1089/thy.2017.0404

Vancouver

Sloth Mathiesen J, Kroustrup JP, Vestergaard P, Krag KS, Poulsen PL, Rasmussen ÅK et al. Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide Study. Thyroid. 2017 Dec;27(12):1505-1510. https://doi.org/10.1089/thy.2017.0404

Author

Sloth Mathiesen, Jes ; Kroustrup, Jens Peter ; Vestergaard, Peter ; Krag, Kirstine Stochholm ; Poulsen, Per Løgstrup ; Rasmussen, Åse Krogh ; Feldt-Rasmussen, Ulla ; Gaustadnes, Mette ; Ørntoft, Torben Falck ; Rossing, Maria ; Nielsen, Finn Cilius ; Albrechtsen, Anders ; Brixen, Kim ; Godballe, Christian ; Frederiksen, Anja Lisbeth. / Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark : a nationwide Study. In: Thyroid. 2017 ; Vol. 27, No. 12. pp. 1505-1510.

Bibtex

@article{01486ec164cc4c0fa5a0497a29f9c2b5,
title = "Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide Study",
abstract = "BACKGROUND: Multiple endocrine neoplasia (MEN) 2A and 2B are caused by REarranged during Transfection (RET) germline mutations. In a recent nationwide study, an unusually high prevalence (33%) of families with the C611Y mutation was reported, and it was hypothesized that this might be due to a founder effect. The first nationwide study of haplotypes in MEN2A families was conducted, with the aim of investigating the relatedness and occurrence of de novo mutations among Danish families carrying similar mutations.METHODS: The study included 21 apparently unrelated MEN2A families identified from a nationwide Danish RET cohort from 1994 to 2014. Twelve, two, two, three, and two families carried the C611Y, C618F, C618Y, C620R, and C634R mutations, respectively. Single nucleotide polymorphism chip data and identity by descent analysis were used to assess relatedness.RESULTS: A common founder mutation was found among all 12 C611Y families and between both C618Y families. No relatedness was identified in the remaining families.CONCLUSION: The data suggest that all families with the C611Y germline mutation in Denmark originate from a recent common ancestor, probably explaining the unusually high prevalence of this mutation. Additionally, the results indicate that the C611Y mutation rarely arises de novo, thus underlining the need for thorough multigenerational genetic work up in carriers of this mutation.",
keywords = "Journal Article",
author = "{Sloth Mathiesen}, Jes and Kroustrup, {Jens Peter} and Peter Vestergaard and Krag, {Kirstine Stochholm} and Poulsen, {Per L{\o}gstrup} and Rasmussen, {{\AA}se Krogh} and Ulla Feldt-Rasmussen and Mette Gaustadnes and {\O}rntoft, {Torben Falck} and Maria Rossing and Nielsen, {Finn Cilius} and Anders Albrechtsen and Kim Brixen and Christian Godballe and Frederiksen, {Anja Lisbeth}",
year = "2017",
month = dec,
doi = "10.1089/thy.2017.0404",
language = "English",
volume = "27",
pages = "1505--1510",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary AnnLiebert, Inc. Publishers",
number = "12",

}

RIS

TY - JOUR

T1 - Founder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark

T2 - a nationwide Study

AU - Sloth Mathiesen, Jes

AU - Kroustrup, Jens Peter

AU - Vestergaard, Peter

AU - Krag, Kirstine Stochholm

AU - Poulsen, Per Løgstrup

AU - Rasmussen, Åse Krogh

AU - Feldt-Rasmussen, Ulla

AU - Gaustadnes, Mette

AU - Ørntoft, Torben Falck

AU - Rossing, Maria

AU - Nielsen, Finn Cilius

AU - Albrechtsen, Anders

AU - Brixen, Kim

AU - Godballe, Christian

AU - Frederiksen, Anja Lisbeth

PY - 2017/12

Y1 - 2017/12

N2 - BACKGROUND: Multiple endocrine neoplasia (MEN) 2A and 2B are caused by REarranged during Transfection (RET) germline mutations. In a recent nationwide study, an unusually high prevalence (33%) of families with the C611Y mutation was reported, and it was hypothesized that this might be due to a founder effect. The first nationwide study of haplotypes in MEN2A families was conducted, with the aim of investigating the relatedness and occurrence of de novo mutations among Danish families carrying similar mutations.METHODS: The study included 21 apparently unrelated MEN2A families identified from a nationwide Danish RET cohort from 1994 to 2014. Twelve, two, two, three, and two families carried the C611Y, C618F, C618Y, C620R, and C634R mutations, respectively. Single nucleotide polymorphism chip data and identity by descent analysis were used to assess relatedness.RESULTS: A common founder mutation was found among all 12 C611Y families and between both C618Y families. No relatedness was identified in the remaining families.CONCLUSION: The data suggest that all families with the C611Y germline mutation in Denmark originate from a recent common ancestor, probably explaining the unusually high prevalence of this mutation. Additionally, the results indicate that the C611Y mutation rarely arises de novo, thus underlining the need for thorough multigenerational genetic work up in carriers of this mutation.

AB - BACKGROUND: Multiple endocrine neoplasia (MEN) 2A and 2B are caused by REarranged during Transfection (RET) germline mutations. In a recent nationwide study, an unusually high prevalence (33%) of families with the C611Y mutation was reported, and it was hypothesized that this might be due to a founder effect. The first nationwide study of haplotypes in MEN2A families was conducted, with the aim of investigating the relatedness and occurrence of de novo mutations among Danish families carrying similar mutations.METHODS: The study included 21 apparently unrelated MEN2A families identified from a nationwide Danish RET cohort from 1994 to 2014. Twelve, two, two, three, and two families carried the C611Y, C618F, C618Y, C620R, and C634R mutations, respectively. Single nucleotide polymorphism chip data and identity by descent analysis were used to assess relatedness.RESULTS: A common founder mutation was found among all 12 C611Y families and between both C618Y families. No relatedness was identified in the remaining families.CONCLUSION: The data suggest that all families with the C611Y germline mutation in Denmark originate from a recent common ancestor, probably explaining the unusually high prevalence of this mutation. Additionally, the results indicate that the C611Y mutation rarely arises de novo, thus underlining the need for thorough multigenerational genetic work up in carriers of this mutation.

KW - Journal Article

U2 - 10.1089/thy.2017.0404

DO - 10.1089/thy.2017.0404

M3 - Journal article

C2 - 29020875

VL - 27

SP - 1505

EP - 1510

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 12

ER -

ID: 186150361